![](/img/cover-not-exists.png)
A randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute pain
Viscusi, Eugene R., Webster, Lynn, Kuss, Michael, Daniels, Stephen, Bolognese, James A., Zuckerman, Seth, Soergel, David G., Subach, Ruth Ann, Cook, Emily, Skobieranda, FranckVolume:
157
Language:
english
Journal:
PAIN
DOI:
10.1097/j.pain.0000000000000363
Date:
January, 2016
File:
PDF, 720 KB
english, 2016